One study showed that pre-administration of anti-VEGF drugs before the induction of colitis in mice could exacerbate the inflammatory response and significantly reduce the vascular density in the colon at the end of the acute phase of inflammation (63). The gene discussed is VEGFA; the disease is colitis.